Brentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin Lymphoma
Clinical trial NCT01393717 · COMPLETED
Trial details
- NCT number
- NCT01393717
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-20
- Primary completion
- 2017-02-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.